ACCELERATING PROGRESS THROUGH COLLABORATION ACCELERATOR AWARD CASE STUDIES
|
|
- Sydney Hodge
- 6 years ago
- Views:
Transcription
1 ACCELERATING PROGRESS THROUGH COLLABORATION ACCELERATOR AWARD CASE STUDIES
2 CRUK CENTRES NETWORK At Cancer Research UK we recognise the crucial role that infrastructure plays in creating a dynamic and responsive research environment. Our 13 Centres and five Institutes form a unique network, facilitating multidisciplinary translational research of the highest international quality and training the next generation of clinicians and researchers. Our Centres drive local partnerships and high-calibre collaborations between universities, NHS trusts and other cancer charities under a united strategy to accelerate the translation of research into the clinic. With an annual budget of over 41m, the network delivers this through: Core funding in excess of 29 million per annum, supporting a network of 13 Centres, covering infrastructure, salaries, seed funding and running expenses Training funding of up to 12m per annum Our Accelerator Award. 2
3 THE ACCELERATOR AWARD The Accelerator Award provides a simple mechanism to support researchers and clinicians to collaborate more closely on large scale translational research projects regardless of location. It supports the development of high-quality resources (including training programmes) that will accelerate progress in translational research through the creation of collaborative international networks. The Award provides up to 1m per annum over five years and supports: Technical staff Project management staff Academic appointments Consumables Equipment Training Networking costs. The outputs will be available to the wider scientific community to stimulate further research through additional leveraged funding. PREVIOUSLY FUNDED PROJECTS Since we launched the Accelerator Award in 2015 we have funded ambitious research projects spanning diverse research areas, modalities and cancer sites. The theme common to all the projects described in this booklet is their collaborative approach to accelerating progress, drawing together resources and expertise which will deliver impact that could not be achieved in isolation. LOOKING FORWARD In 2017 we formed a new funding partnership with the Fundación Científica de la Asociación Española Contra el Cáncer (FC AECC, the principal cancer research charity in Spain) and the Associazione Italiana per la Ricerca sul Cancro (AIRC, the principal cancer research charity in Italy). The partnership will facilitate access to a wide pool of expertise and resources, encouraging international collaboration across Spain, Italy and the UK. 3
4 ACCELERATOR AWARD CASE STUDIES PAGE AWARD TITLE 5 A NATIONAL DIGITAL PATHOLOGY AND IMAGE ANALYSIS PLATFORM FOR SOLID TUMOURS 6 THE FRANCIS CRICK INSTITUTE: CLINICAL TRAINING AWARD 7 DRUG DISCOVERY USING A NETWORKED STRUCTURAL BIOLOGY RESOURCE 8 CANCER IMMUNOTHERAPY CATALYST NETWORK 9 INTERNATIONAL GLIOMA CELLULAR GENETICS RESOURCE 10 ADVANCED RADIOTHERAPY TECHNOLOGIES NETWORK (ART-NET) 11 SUCCESS DETERMINANTS AND MECHANISMS OF TUMOUR IMMUNOTHERAPY A NATIONAL POST-MORTEM TISSUE COLLECTION PROTOCOL (THE PEACE STUDY) 14 LUNG CANCER CENTRE OF EXCELLENCE 4
5 A NATIONAL DIGITAL PATHOLOGY AND IMAGE ANALYSIS PLATFORM FOR SOLID TUMOURS This 4.0m Award, led by the Queen s University Belfast, will establish standardised, quantitative methods of tissue and cellular imaging analysis in molecular pathology, to enhance the discovery of diagnostic and therapeutic biomarkers in solid cancers. The consortium will: Build digital analysis platforms and promote knowledge exchange, particularly between the hub of immunology expertise in Southampton and the hub of molecular pathology expertise in Belfast Invest in the next generation of molecular pathologists by developing a Masters in Molecular Pathology course and funding a clinical research training programme Principal Investigator: Professor Manuel Salto-Tellez (Belfast) EDINBURGH BELFAST NEWCASTLE MANCHESTER London University College London Institute of Cancer Research LONDON SOUTHAMPTON 5
6 THE FRANCIS CRICK INSTITUTE: CLINICAL TRAINING AWARD This 4.2m Award, led by the Francis Crick Institute, aims to build capacity in experimental cancer medicine through training the next generation of cancer scientists. Principal Investigator: Professor Richard Treisman (Francis Crick Institute) The programme will: Develop a unique clinical research fellow training programme in collaboration with five major research institutions in London: Barts Cancer Institute, Institute of Cancer Research, Imperial College London, King s College London and University College London. This will deliver support to researchers working on molecular archeology, cancer immunotherapy, and targets for ovarian cancer therapies Support the annual Crick Cancer Meeting, which will facilitate crosscollaboration within and outside of the immediate network London LONDON 6 The Francis Crick Institute King s College London Queen Mary University London University College London Imperial College London Institute of Cancer Research
7 DRUG DISCOVERY USING A NETWORKED STRUCTURAL BIOLOGY RESOURCE This 1.8m Award, led by the University of Leicester, will establish a virtual structural biology resource to improve target validation for drug development, generating high quality data and accelerating research in personalised medicine. Principal Investigators: Professor Mark Carr (Leicester) Professor Richard Bayliss (Leeds) The consortium will: Enhance access to equipment for and provide expertise in protein production, biophysics, fragment screening, computational chemistry and structural biology research across the network Coordinate the range of facilities and expertise available to provide a comprehensive resource for target validation Share best practice and help to standardise protocols Host workshops and symposia to build capacity, promote networking and train future researchers GLASGOW BELFAST NEWCASTLE London Institute of Cancer Research LEEDS MANCHESTER LEICESTER LONDON 7
8 CANCER IMMUNOTHERAPY CATALYST NETWORK This 5.0m Award, led by the CRUK UCL Centre, investigates the monitoring of patients being treated with immunotherapies, to identify mechanisms and markers of response, resistance and toxicity. The consortium will also research pre-clinical novel therapies, such as adoptive cellular therapies, to help get them to the clinic. The two teams will work together to create new immunotherapies and validate potential targets and combinations. Principal Investigators: Professor Henning Walczak (UCL) The consortium will: Establish a state-of-the-art immunemonitoring and discovery hub, which will provide a comprehensive assessment of patient response (using cytometry, immunohistochemistry, genomics, proteomics and bioinformatics) Build a basic research team to develop mechanistic insights and meaningful prognostic and diagnostics markers Build a translational research team skilled in cancer immunotherapeutics, biotherapeutic production and T-cell engineering Support a training programme in immuno-oncology clinical trials to upskill the next generation of scientists and clinicians to develop, interpret and deliver relevant trials for immunotherapies LONDON London The Francis Crick Institute Barts Cancer Institute University College London Institute of Cancer Research King s College London 8
9 INTERNATIONAL GLIOMA CELLULAR GENETICS RESOURCE This 3.7m Award, led by the CRUK Edinburgh Centre, will develop new, open-access resources for brain cancer research through the generation of glioblastoma (GBM) cell lines and diverse cellular models. Principal Investigator: Dr Steve Pollard (Edinburgh) We have the opportunity to get an unprecedented level of genetic and molecular detail, enabling us to create a complete catalogue of the different types of brain tumours. Dr Steven Pollard The consortium will: Develop centralised infrastructure for the generation, cataloguing and curation of glioblastoma cell lines Develop standardised, high quality, primary human cellular GBM models across different subtypes as well as normal stem cell controls Develop genome editing core facilities and novel engineered human patientderived cellular models Develop an open-source database for the glioma community Support a training programme that will be co-supervised by developmental neurobiologists at the Francis Crick Institute EDINBURGH London The Francis Crick Institute University College London Institute of Cancer Research Queen Mary University London LONDON 9
10 ADVANCED RADIOTHERAPY TECHNOLOGIES NETWORK (ART-NET) This 4.3m Award, led by the CRUK ICR Centre, will optimise and harmonise the use of three new radiotherapy technologies (Stereotactic Ablative Radiotherapy, MR-Linac and Proton Beam Therapy) as they transition into the clinic. Principal Investigator: Professor Kevin Harrington (ICR) The consortium will: Establish a national cooperative around these technologies Create a digital platform to enable adaptive treatment planning and protocol development Assess the health economics of new treatment approaches against existing care Support a training programme investing in the next generation of radiation oncologists We d like to see radiotherapy becoming more targeted so we can give bigger doses in fewer treatments. Professor Kevin Harrington LEEDS MANCHESTER London University College London Institute of Cancer Research OXFORD LONDON 10
11 SUCCESS DETERMINANTS AND MECHANISMS OF TUMOUR IMMUNOTHERAPY This 3.9m Award, led by the CRUK Southampton Centre, will enable researchers to monitor patients with melanoma, lung and oesophageal cancers being treated with immunotherapeutics to determine how the tumours are recognised in vivo and influenced by immunotherapy. This aims to inform the rational design of immunotherapies, as well as evaluate how patients are likely to respond to treatment and who will benefit most. The consortium will: Combine the expertise in cancer immunotherapy in Southampton and the experience in single cell genomics and basic immunology in Oxford Support an international collaboration with the La Jolla Institute for Allergy and Immunology, based in California, which will perform micro-scaled transcriptomatic analysis of samples We hope to be able to come up with ways to predict how likely any given immunotherapy is to help a patient. Professor Tim Elliott Principal Investigator: Professor Tim Elliot (Southampton) La Jolla Institute for Allergy and Immunology, California OXFORD SOUTHAMPTON 11
12 A NATIONAL POST-MORTEM TISSUE COLLECTION PROTOCOL (THE PEACE STUDY) This 4.0m Award, led by the CRUK UCL Centre, will support the longitudinal collection of biological samples from patients with primary brain or metastatic cancer across the UK, including after their death. Sample collection will comprise tissue, blood, cell-free DNA and circulating tumour cells. Principal Investigator: Professor Charles Swanton (UCL/Francis Crick) The consortium will: Coordinate and standardise sample collection across the network Create a digital pathology hub from the samples Train clinical researchers in autopsy pathology This will create a unique resource of samples, supported by clinical annotation, to investigate through research initiatives such as understanding the evolution of cancer, intratumour heterogeneity, mechanisms of resistance, as well as identification of prognostic and diagnostic markers. GLASGOW ST ANDREWS BELFAST London The Francis Crick Institute University College London MANCHESTER LEICESTER CAMBRIDGE LONDON 12
13 THE PEACE STUDY A PATIENT S PERSPECTIVE The roll-out of this study will give patients a choice to contribute to research after their death. Maggie Wilcox, a retired nurse from Surrey and breast cancer survivor, is a patient advocate with the Independent Cancer Patient Voice for the PEACE trial. As a cancer survivor, I understand that a cancer diagnosis can be very stressful for the patient and their families. And doctors and families are often hesitant to talk about contributing a patient s body to research after death. But I think it s important to give the patient a choice to contribute to research that will help save others lives. And often patients are a lot tougher than they may seem. It s an opportunity to create something positive out of a difficult experience. I hope one day that donating tissue after death is as normal as donating blood. Maggie Wilcox 13
14 LUNG CANCER CENTRE OF EXCELLENCE In June 2014, we awarded 2.5m over three years for a Lung Cancer Centre of Excellence. The Centre, which is a partnership between researchers at University of Manchester and University College London, was established to provide a focal point for our ambition to improve lung cancer survival. The award will enable the Centre to: Provide leadership to the UK and international lung cancer research community in basic, translational and clinical research Develop infrastructure to support translational and clinical research Establish a critical mass for lung cancer research in the UK Train the next generation of lung cancer researchers Leads: Professor Caroline Dive (University of Manchester) and Professor Charles Swanton (UCL) For more information please visit cruklungcentre.org 14
15 GET IN TOUCH Cancer Research UK Angel Building, 407 St John Street, London EC1V 4AD, UK T: +44(0) For more information: Dr Sarah Brown Research Funding Manager T: +44 (0)
16
NIHR Supporting collaboration in life sciences research
NIHR Supporting collaboration in life sciences research Dr Matt Hallsworth - Head of External Relations, NIHR Office for Clinical Research Infrastructure (NOCRI) Research funders build capabilities and
More informationDefining a research programme in advanced radiotherapy
Defining a research programme in advanced radiotherapy Dr Ann Henry Associate Professor in Clinical Oncology a.henry@leeds.ac.uk Leeds Radiotherapy Research Group 2008 Move to Bexley State of art equipment
More informationFunding research for the future
Funding research for the future Dr Helen Compton (helen.compton@nihr.ac.uk) Stakeholder Engagement Manager NIHR, Central Commissioning Facility The future of health and social care depends on today's research
More information2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening
More informationKaren Brown (University of Leicester)
Karen Brown (University of Leicester) Chemoprevention in October 2013. Basic Translational Early phase trials Late phase trials Epidemiology Unique multidisciplinary team with National Coverage Brings
More informationGrand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15
Grand Challenge and other funding opportunities at Cancer Research UK Jamie Meredith, 9 th Dec 15 Multidisciplinary research at CRUK OVERVIEW About CRUK CRUKs research strategy A focus on multidisciplinary
More informationESMO 2020 VISION. esmo.org
ESMO 2020 VISION esmo.org CARING FOR PEOPLE WITH CANCER Cancer patients and their needs are at the centre of all that we do: our profession is driven by our determination, individually and collectively,
More informationRESEARCH ENGAGEMENT PRIZES 2015
RESEARCH ENGAGEMENT PRIZES 2015 RESEARCH ENGAGEMENT PRIZES 2015 RESEARCH ENGAGEMENT AT CANCER RESEARCH UK Research engagement is vital to the work of, and we couldn t do it without the dedicated scientists,
More informationNCRI Biomarkers & Imaging CSG Cell-free DNA workshop
NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended
More informationAnthony Chalmers University of Glasgow
Radiotherapy-drug combinations for NSCLC: current and potential UK collaborative initiatives Anthony Chalmers University of Glasgow UK SABR Consortium 25th November 2016 Increase tumour control and cure
More informationMoorfields Eye Charity Strategy People's sight matters
Moorfields Eye Charity Strategy 2018-2024 People's sight matters Welcome to the strategy for Moorfields Eye Charity 2018-2024 Our strategy builds on the Vision of Excellence strategy from Moorfields Eye
More informationThe 100,000 Genomes Project
The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England
More informationConsensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018
Consensus statement between CM-Path, CRUK and the PHG Foundation following on from the Liquid Biopsy workshop on the 8th March 2018 Summary: This document follows on from the findings of the CM-Path The
More informationplasma MATCH Andrew Wardley,
in partnership with plasma MATCH A multiple parallel cohort, open-label, multi-centre phase IIa clinical trial of circulating tumour DNA screening to direct targeted therapies in patients with advanced
More informationPRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER
PRESS RELEASE FOR IMMEDIATE RELEASE SINGAPORE INSTITUTES COLLABORATE WITH SAMSUNG MEDICAL CENTER TO IMPROVE TREATMENT OF LIVER CANCER This collaboration creates the world s first clinically reliable and
More informationAddiction and substance misuse
Addiction and substance misuse Research Strategy Addiction and substance misuse Research Strategy Contents Introduction 1 Overview 2 Rationale 2 Achievements 3 Timeline 4 Research supported through the
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationAiming High Our priorities by 2020 HALFWAY THERE. Our priorities by 2020
HALFWAY THERE Our priorities by 2020 2 In 2015 we published a vision for where we would like CLIC Sargent to be by 2025, Aiming High: Our ambitions for children and young people with cancer. We have already
More informationBuilding on Success. Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance. May 2015
Building on Success Driving improvements in clinical outcomes through a Greater Manchester Cancer Alliance May 2015 Introduction Cancer care in Greater Manchester has seen significant improvements in recent
More informationTreatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK
Treatments of tomorrow: dementia research and drug discovery Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK More failure What is different about dementia drug discovery? The
More informationAgenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,
More informationPIONEERING RESEARCH 2016/17
PIONEERING RESEARCH 2016/17 OUR ANNUAL RESEARCH PUBLICATION CONTENTS HIGHLIGHTS 2 50 Welcome from Investing in the future: Iain Foulkes How our fellowships make a difference 4 16 Tackling hard-to-treat
More informationPublished December 2015
Published December 2015 Contents Executive summary 3 1. Introduction The changing story of cancer 6 2. Current state Poor performance 7 Fragmentation and duplication 7 Existing and developing programme
More informationMODULATING TISSUE IMMUNITY INNOVATION WORKSHOP CALL FOR APPLICATIONS
MODULATING TISSUE IMMUNITY INNOVATION WORKSHOP CALL FOR APPLICATIONS 1 Modulating Tissue Immunity Innovation Workshop If you would like to transform the treatment of cancer and musculoskeletal conditions
More informationYour Health Topic : Genomics and Clinical Practice How genetics is improving care for patients
Your Health Topic : Genomics and Clinical Practice How genetics is improving care for patients Speaker Dr Kevin Monahan FRCP PhD Consultant Gastroenterologist, Family History of Bowel Cancer Clinic, Chelsea
More informationCancer and Nutrition NIHR infrastructure collaboration. Improving cancer prevention and care. For patients. For clinicians. For researchers.
Cancer and Nutrition NIHR infrastructure collaboration Improving cancer prevention and care. For patients. For clinicians. For researchers. Report of Phase Two July 2015 - March 2017 Preface The purpose
More informationCANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES
CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES Cancers of Unmet Need: Our Ambition Over the last 40 years, improvements in prevention, detection and treatment have revolutionised cancer medicine and survival
More informationFrom Front Room to Research Laboratory -How Alström Syndrome UK made that Journey
From Front Room to Research Laboratory -How Alström Syndrome UK made that Journey Mike Hales ASUK Programme Manager 1 The Challenge Alström Syndrome is a recessive genetic condition with
More informationThe summit and its purpose
Sponsors: 1 The summit and its purpose The Translational Hearing Research Summit: Biological and Pharmacological Approaches was an international summit that gathered 159 delegates, from 14 countries to
More informationProgress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:
SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental
More informationstroke.org.uk Supporting world-class stroke research in Scotland
stroke.org.uk Supporting world-class stroke research in Scotland Stroke research saves lives and transforms care Stroke is a sudden and devastating condition which can take and transform lives in an instant.
More informationNHS ENGLAND BOARD PAPER
NHS ENGLAND BOARD PAPER Paper: PB.15.12.2016/04 Title: Taking the cancer strategy forward: programme update Lead Director: Professor Sir Bruce Keogh, National Medical Director Cally Palmer, National Cancer
More informationESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME
ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME Christoph Zielinski Chair of the ESMO Fellowship & Award Committee esmo.org ESMO FELLOWSHIP PROGRAMME Exclusive to ESMO members under 40 years old
More informationSAVING LIVES: ACHIEVING MORE
SAVING LIVES: ACHIEVING MORE ANTHONY NOLAN ORGANISATIONAL STRATEGY FOR 2015-2018 WHERE WE RE COMING FROM In 1974, we were the world s first stem cell donor register. And over 40 years later, we re at the
More informationThomas C. Wilmot, Sr. Judy Wilmot Linehan
Thomas C. Wilmot, Sr. Judy Wilmot Linehan The Wilmot Family For more than 35 years, the Wilmot family has been dedicated to supporting cancer research and care for the Rochester community. Their generosity
More informationEPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
More informationPIONEERING RESEARCH OUR ANNUAL RESEARCH PUBLICATION
PIONEERING RESEARCH 2014 15 OUR ANNUAL RESEARCH PUBLICATION CONTENTS 2 Welcome from Iain Foulkes 3 Our strategic priorities 4 Our funding facts and figures 2014/15 funding and success rates for our committees
More informationBriTROC personalised biomarkers in relapsed ovarian high grade serous carcinoma
BriTROC personalised biomarkers in relapsed ovarian high grade serous carcinoma GCIG Translational Committee 4 th June 2016 Iain McNeish Professor of Gynaecological Oncology Wolfson Wohl Cancer Research
More informationMovember s funds in action:
IDENTIFICATION OF NEW DRUGS FOR PROSTATE CANCER Scientists at the Blizard Institute, Queen Mary University of London are investigating new drug treatments for men with prostate cancer. They ve already
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationLead Supervisor 1: Physics Supervision Name: Matthew Grech-Sollars Institution/Department: Imperial College London: Department of Surgery & Cancer
Project Title: Development of MRI brain tumour fingerprinting for clinical assessment of brain tumour biology Lead Supervisor 1: Physics Supervision Name: Matthew Grech-Sollars Institution/Department:
More informationA World Free From Cancer. BC Cancer Foundation 2011 Report to Donors
A World Free From Cancer BC Cancer Foundation 2011 Report to Donors For the year ended March 31, 2011 Table of Contents Page 3 Page 5 Partners in Discovery A Message from the BC Cancer Foundation Chairman
More informationNCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
More informationUCL-Advanced Diagnostics. 2015/16 Service Update
UCL-Advanced Diagnostics 2015/16 Service Update About UCL-Advanced Diagnostics UCL Advanced Diagnostics (UCL-AD) is the immunohistochemistry, in situ and molecular diagnostics service arm of the UCL-Cancer
More informationHealth Science in the NHS:
Health Science in the NHS: Getting Ready to Apply Genomic Knowledge into the NHS Angela Douglas, Scientific Director 16 th April 2014 Content of Talk What is Genomics the Science What Genomics can do for
More informationFarhat Din University of Edinburgh
Farhat Din University of Edinburgh number cannot treat our way out of cancer Chris Wild, IARC PubMed 180000 160000 140000 120000 100000 80000 60000 40000 20000 0 1800 1850 1900 1950 2000 2050 Year cancer
More informationPIONEERING RESEARCH
PIONEERING RESEARCH 2012-13 Pioneering Research 01 CONTENTS Welcome from Harpal Kumar and Iain Foulkes 3 Our Funding Facts and Figures 4 Investing in Our Network 6 Initiatives 8 The Francis Crick Institute
More informationFarhat Din University of Edinburgh
Farhat Din University of Edinburgh number cannot treat our way out of cancer Chris Wild, IARC PubMed 180000 160000 140000 120000 100000 80000 60000 40000 20000 0 1800 1850 1900 1950 2000 2050 Year cancer
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationVISION» FOCUS DISCOVERY» CREATION
The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater
More informationStrategy Registered Charity
Strategy 2015-2025 Registered Charity 516898 Why do we exist? Yorkshire has the third worst cancer incidence rates in England. 11 of 13 local authorities in the county have outcomes below the national
More informationThe Wistar Institute is an international leader in biomedical
A LEADER IN RESEARCH The Wistar Institute is an international leader in biomedical research with special expertise in cancer, immunology and infectious disease research. The Institute works actively to
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationForeword. Our shared principles
Our Digital Future Foreword The way we manage our lives is changing. 86% of households now have internet access, 82% of people go online every day and 72% of adults use a smartphone 1. It is now time to
More informationType 1 Research Today
Type 1 Research Today A healthy landscape for supporting type 1 diabetes research jdrf.org.uk UK funding organisations are investing close to 100 million in type 1 research This is testament to the quality
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More informationDeveloping effective ctdna testing services for lung cancer. Executive summary
Developing effective ctdna testing services for lung cancer Executive summary September 2017 Authors: Laura Blackburn, Leila Luheshi, Sandi Deans, Mark Kroese, Hilary Burton Acknowledgements: The PHG Foundation
More informationGenomics and personalised prevention
30 September 2016 1 Genomics and personalised prevention Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health European Health Forum, Gastein 29 September 2016 About me Tom Deputy Chief Scientist
More informationPOTENTIAL FOR MERGER: THE BRAIN TUMOUR CHARITY SECTOR
POTENTIAL FOR MERGER: THE BRAIN TUMOUR CHARITY SECTOR The brain tumour charity landscape is moving from fragmentation to greater coordination Brain tumour charities support people who have or had brain
More informationPatient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility
Patient and Public Involvement, Engagement and Participation Strategy 2017-2022 NIHR Newcastle Clinical Research Facility Context The NIHR Newcastle Clinical Research Facility (CRF) delivers high quality,
More informationIntroduction. Underpinning these themes is the aspiration of NHS R&D NW to:
PROSPECTUS 2015 16 Introduction Welcome to the new NHS Research & Development North West (NHS R&D NW) prospectus for 2015-16. This year we are building on our key themes of enabling Connections, developing
More informationREGISTER TO ATTEND THIS FREE EVENT. brisbane diamantina health partners
BDHP Brain and Mental Health Conference Translational research in Neuroscience: Bridging the gap between basic science and clinical practice Tuesday 28 August 2018 Bancroft Auditorium QIMR Berghofer Medical
More informationUC Brain Tumor Center Molecular Therapeutics Pilot Grant Program 2013/2014
Introduction An estimated 25,000 new cases of primary brain tumors will be diagnosed in the United States in 2013, and an estimated 170,000 patients will be diagnosed with brain metastases, most often
More informationResearch & Information Officer
Research & Information Officer Job Information Pack February 2018 info@bcrt.org.uk www.bcrt.org.uk 0113 258 5934 About the Bone Cancer Research Trust In 2004, a group of families who had lost children
More informationGovernment backs new high tech early dementia assessment service to reduce time to diagnosis from 18 months to 3 months
Page 1. Government backs new high tech early dementia assessment service to reduce time to diagnosis from 18 months to 3 months Novel digital healthcare system to be trialled from early 2013 combines world-class
More informationR e s e a r c h S t r a t e g y
Sheffield Teaching Hospitals NHS Foundation Trust Academic Directorate of Specialised Cancer R e s e a r c h S t r a t e g y Academic Directorate of Specialised Cancer Research Strategy Executive Summary
More informationC A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S
Cancer Research Cluster to Facilitate and Structure Oncology Research C A N C É R O P Ô L E L Y O N A U V E R G N E R H Ô N E - A L P E S s P E E D I N G U P P R O G R E S S CANCÉROPÔLE LYON AUVERGNE RHÔNE-ALPES
More informationNHS England Diabetes Programme Update June 2018
NHS England Diabetes Programme Update June 2018 Professor Jonathan Valabhji National Clinical Director for Obesity and Diabetes, NHS England Consultant Diabetologist, Imperial College Healthcare NHS Trust
More informationRESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016
RESEARCHER DEVELOPMENT DAYS 2016/2017 Wednesday 30 November 2016 Seminar Room 02/6008, 2 nd Floor UCL Centre for Nephrology Royal Free Hospital Rowland Hill Street London, NW3 2PF DELEGATE PACK Kidney
More informationStrategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network
Strategic Operational Research Plan 2017-2018 February 13, 2017 Digestive Health Strategic Clinical Network DH SCN Strategic Operational Plan The of the Digestive Health Strategic Clinical Network The
More informationDOING IT YOUR WAY TOGETHER S STRATEGY 2014/ /19
DOING IT YOUR WAY TOGETHER S STRATEGY 2014/15 2018/19 Why is Together s role important? Experiencing mental distress is frightening and can lead to long-term disadvantage. Mental illness still carries
More informationService Improvement - Strategic. Service Improvement - Strategic. Regional Oncology Communications and Health Promotions
Service Improvement - Strategic Service Improvement - Strategic Regional Oncology Communications and Health Promotions Development of Radiation Oncology Services The evaluation process for the development
More informationThe Cancer Prevention Initiative
The Cancer Prevention Initiative A model for increasing capacity in policy translatable behavioral and lifestyle research Session code: 28-T1 Track 1 Disclosure of interest: N/A CONTENTS The 4 Pillars
More informationA Youth Sector Summary of the Civil Society Strategy. Youth Work Youth Participation Funding for Young People NCS
A Youth Sector Summary of the Civil Society Strategy Youth Work Youth Participation Funding for Young People NCS Youth Work (Pages 41-42) The government is committed to making sure all young people have
More informationDelivering a Translational Agenda in Cancer: the Development of the Centre for
Delivering a Translational Agenda in Cancer: the Development of the Centre for Clinical Haematology C Craddock, School of Cancer Studies, University of Birmingham and Queen Elizabeth Hospital, Birmingham
More informationBORDET DEPARTMENT RADIATION ONCOLOGY
BORDET DEPARTMENT RADIATION ONCOLOGY The Radiation Oncology Department has been providing patients with high quality, tailored radiation oncology care for the last 60 years in a multidisciplinary setting
More informationAn Extraordinary Resource for Cancer Care
An Extraordinary Resource for Cancer Care Anderson Family Cancer Institute The Campaign for Jupiter Medical Center Gaining Critical Mass Against Cancer $50 Million fundraising goal to build our new cancer
More informationRichard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead
GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,
More informationEnd of Grant Report. Registered Charity
End of Grant Report Dr Sally George. Report at the end of the grant by Christopher s Smile for the 3 year position of Clinical research Fellow in the Paediatric Solid Tumour Biology Team at The Institute
More informationCANCER Annual Report
2016 CANCER Annual Report A WORD FROM OUR LEADERSHIP We are pleased to present our 2016 Annual Report highlighting advances in state of the art cancer care at the Roper St. Francis Cancer Program. Our
More informationBREAST CANCER NOW RESEARCH CENTRE ICR CHELSEA, LONDON. Higher Scientific Officer
BRAST CANCR NOW RSARCH CNTR ICR CHLSA, LONON Higher Scientific Officer The Institute of Cancer Research, London, is one of the world s most influential cancer research institutes, with an outstanding record
More informationResearch Strategy
Research Strategy 2017 2021 Autistica is a unique and highly respected autism research funder. They have become renowned for identifying and prioritising some of the most critical challenges within autism
More informationPOST SHOW REPORT EXCEL JUNE 6 & 7 LONDON HEAD & NECK GASTROINTESTINAL RUNNING ALONGSIDE DIAGNOSTIC SURGICAL REHABILITATION BRAIN STIMULATION
MAIN SPONSOR & 7 JUNE EXCEL LONDON HEAD & NECK GASTROINTESTINAL LUNG POST SHOW REPORT PART OF MEDICAL RUNNING ALONGSIDE DIAGNOSTIC SURGICAL REHABILITATION BRAIN STIMULATION PARTNERS 1, We had a great show
More informationTaking on research to change the future. Five year research strategy
Taking on research to change the future Five year research strategy By 2026, pancreatic cancer will be the fourth biggest cancer killer in the UK, unless research funding is dramatically increased. Pancreatic
More informationAlcohol Research UK Research Strategy
Alcohol Research UK Research Strategy 2015-18 Supporting research to reduce alcohol-related harm www.alcoholresearchuk.org Alcohol Research UK Research Strategy 2015-18 Foreword Professor Alan-Maryon Davies
More informationClinical oncology workforce: the case for expansion Faculty of Clinical Oncology
www.rcr.ac.uk Clinical oncology workforce: the case for expansion Faculty of Clinical Oncology www.rcr.ac.uk Contents Foreword 2 1. Background information 3 What do clinical oncologists do? 3 Why is the
More informationActivity Report April 2012 March 2013
Colorectal Cancer Managed Clinical Network Activity Report April 2012 March 2013 Paul Horgan Professor of Surgery MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationYour Excellency, Mr Paul Madden, British High Commissioner, Singapore. It is a great pleasure to welcome all of you to the Biopolis for this two-day
OPENING SPEECH BY MR LIM CHUAN POH, CHAIRMAN, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, AT THE UK-SINGAPORE SYMPOSIUM ON P53: THE NEXT 30 YEARS, 25 NOVEMBER 2009 @ 0900HRS @ BREAKTHROUGH THEATRETTE,
More informationInternational Symposium on Malignant Pleural Mesothelioma
International Symposium on Malignant Pleural Mesothelioma LONDON 2015 Friday 6th & Saturday 7th November 2015 Jumeirah Carlton Tower Hotel Cadogan Place Knightsbridge London SW1X 9PY United Kingdom Dear
More informationTranslational Clinical Research, the Key to Personalised Healthcare in Practice
New Models of Collaborations with Academia to foster Translational Clinical Research, the Key to ersonalised Healthcare in ractice Exploratory Clinical Development World Europe Conference 2012 London,
More informationPaediatrics and Neuro-development MIC Theme 7
Brain Injury MedTech Co-operative Paediatrics and Neuro-development MIC Theme 7 Professor David Rowitch & Professor Topun Austin The is a partnership between the Cambridge University Hospitals NHS Foundation
More informationA Blueprint for Breast Cancer Deadline 2020
A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing
More informationPublic Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit
Public Engagement and Public and Patient Involvement NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit Our vision Patients, their carers and the wider public are a fundamental and
More informationRM Partners Accountable Cancer Network
The Royal Marsden RM Partners Accountable Cancer Network Dr. Shelley Dolan, Chief Nurse The Royal Marsden Executive Director Cancer Vanguard 1 Overview of the Cancer Vanguard Dr Shelley Dolan Executive
More informationMasDA Mastectomy Decisions Audit 2015
MasDA Mastectomy Decisions Audit 2015 AUDIT PROTOCOL FULL TITLE Mastectomy Decisions Audit: a prospective, multi-centre, population-based audit SHORT TITLE MasDA CHIEF INVESTIGATORS Mrs Jagdeep K Singh,
More informationMaking a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:
Making a Difference Highest quality care. Education. Research. Innovation. OUR MISSION: To deliver world-class care on a daily basis to our patients using the most advanced technologies available. To conduct
More informationTransforming cancer care: the bigger picture and what's next
Transforming cancer care: the bigger picture and what's next Session plan Introduction and progress of the National Cancer Programme The future of NHS cancer care in the long term plan for cancer Discussion
More informationJOB DESCRIPTION. Youth & Community Development Officer (Lothian) Supporting our Transgender Work. April 2018
JOB DESCRIPTION Youth & Community Development Officer (Lothian) Supporting our Transgender Work April 2018 Closing Date: Thursday 17 th May, (4pm) Interview Date: Friday 1 st June 2018 Contract Details:
More informationTranslating MRS into clinical benefit for children with brain tumours
Translating MRS into clinical benefit for children with brain tumours Andrew Peet NIHR Research Professor Childhood Cancer The Facts Cancer is the most common cause of death from disease in childhood Brain
More informationMaking the discoveries
Making the discoveries Our strategy to defeat cancer 2016 21 Our vision We will overcome the challenges posed by cancer s complexity, adaptability and evolution through scientific and clinical excellence,
More information